2023-11-06 13:09:53 ET
- Mersana Therapeutics ( NASDAQ: MRSN ) is scheduled to announce Q3 earnings results on Tuesday, November 7th, before market open.
- The consensus EPS Estimate is -$0.34 and the consensus Revenue Estimate is $8.68M (+55.8% Y/Y).
- Over the last 1 year, MRSN has beaten EPS estimates 0% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 2 downward. Revenue estimates have seen 4 upward revisions and 1 downward.
For further details see:
Mersana Therapeutics Q3 2023 Earnings Preview